Divi's Laboratories Approves Financial Results for March 31, 2026, Recommends Dividend

Divi's Laboratories Approves Financial Results for March 31, 2026, Recommends Dividend​

Divi's Laboratories Limited announced on May 23, 2026, the approval of its standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. The Board of Directors also recommended a final dividend for the financial year 2025-26.

The Company reported significant consolidated financial performance for the year ended March 31, 2026. The consolidated total income stood at 11067 Crores, compared to 9712 Crores in the previous financial year. For the current quarter, the consolidated total income was 2986 Crores, up from 2671 Crores in the corresponding quarter of the previous year.

Financial Performance Overview​

On a standalone basis, the financial results showed the following progression:


The consolidated results for the year ended March 31, 2026, reported a total income of 11067 Crores and a Profit After Tax (PAT) of 2568 Crores.

Balance Sheet and Cash Flow Snapshot​

The audited financial statements reveal a substantial growth in both assets and liabilities compared to the previous fiscal year:

Consolidated Total Assets:
The total assets for the Group reached 20033 Crores as of March 31, 2026, compared to 16932 Crores on the same date last year.

Consolidated Total Equity and Liabilities:
The consolidated total equity for the Group stood at 16761 Crores, increasing from 14969 Crores.

Consolidated Cash Flow Highlights:

• Net cash inflow from operating activities: The Group reported 2738 Crores in net cash inflow from operating activities for the year ended March 31, 2026, compared to 1653 Crores for the previous year.
• Cash and Cash Equivalents: The closing balance of cash and cash equivalents was 128 Crores as of March 31, 2026, compared to 415 Crores on March 31, 2025.

Dividend Recommendation and AGM Details​

During the board meeting held on May 23, 2026, the Board of Directors recommended a final dividend of ₹ 30/- per equity share, representing a 1,500% payout, for the financial year 2025-26. This recommendation is subject to the approval of the members at the ensuing Annual General Meeting (AGM).

The details for the dividend payout and the meeting are as follows:

• Annual General Meeting (AGM): August 10, 2026
• Record Date for Dividend: July 24, 2026

Financial Statements Summary (Crores)​

The audited statements provide a detailed view of the Group's financial standing:

Consolidated Statement of Assets and Liabilities


Standalone Statement of Assets and Liabilities

DIVISLAB Stock Price Movement​

On Friday, Divi's Laboratories Limited shares edged higher, gaining 0.61% and settling at ₹6,887. The stock saw notable activity, closing out the session on a substantial traded volume of 354,149 shares.